157 related articles for article (PubMed ID: 34232382)
1. Eukaryotic initiation factor-2, gamma subunit, suppresses proliferation and regulates the cell cycle via the MAPK/ERK signaling pathway in acute myeloid leukemia.
Lu J; Chen S; Tan H; Huang Z; Li B; Liu L; Chen Y; Zeng X; Zou Y; Xu L
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3157-3168. PubMed ID: 34232382
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of diacylglycerol kinase zeta (DGKZ) induces apoptosis and G2/M phase arrest in human acute myeloid leukemia HL-60 cells through MAPK/survivin/caspase pathway.
Li H; Dong C; Tian Y; Li X; Wang B; Zhai D; Bai Y; Chao X
Pharmazie; 2019 Jul; 74(7):418-422. PubMed ID: 31288898
[TBL] [Abstract][Full Text] [Related]
3. LncRNA ANRIL promotes cell proliferation, migration and invasion during acute myeloid leukemia pathogenesis via negatively regulating miR-34a.
Wang CH; Li QY; Nie L; Ma J; Yao CJ; Chen FP
Int J Biochem Cell Biol; 2020 Feb; 119():105666. PubMed ID: 31830533
[TBL] [Abstract][Full Text] [Related]
4. Anti-leukemic effect of 2-pyrone derivatives via MAPK and PI3 kinase pathways.
Yoon JS; Won YW; Kim SJ; Oh SJ; Kim ES; Kim BK; Cho CG; Choi JH; Park BB; Lee MH; Lee YY
Invest New Drugs; 2012 Dec; 30(6):2284-93. PubMed ID: 22526834
[TBL] [Abstract][Full Text] [Related]
5. SPRY1 promotes cell proliferation and inhibits apoptosis by activating Hedgehog pathway in acute myeloid leukemia.
Lv G; Wang Y; Ji C; Shi C; Li Y
Hematology; 2022 Dec; 27(1):1-10. PubMed ID: 34957932
[TBL] [Abstract][Full Text] [Related]
6. Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways.
Lian X; Lin YM; Kozono S; Herbert MK; Li X; Yuan X; Guo J; Guo Y; Tang M; Lin J; Huang Y; Wang B; Qiu C; Tsai CY; Xie J; Gao ZJ; Wu Y; Liu H; Zhou XZ; Lu KP; Chen Y
J Hematol Oncol; 2018 May; 11(1):73. PubMed ID: 29848341
[TBL] [Abstract][Full Text] [Related]
7. The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia.
Nakamura S; Hirano I; Okinaka K; Takemura T; Yokota D; Ono T; Shigeno K; Shibata K; Fujisawa S; Ohnishi K
Carcinogenesis; 2010 Nov; 31(11):2012-21. PubMed ID: 20823107
[TBL] [Abstract][Full Text] [Related]
8. [The role and mechanism of lncRNA C9ORF139 targeting miR-24-3P/TAOK1 in regulating the proliferation of acute myeloid leukemia cells].
Qin W; Cai XH; Han WM; Lu XZ; Chen MY; Jia ZX; Liu J; Xiao R; Qian SX
Zhonghua Yi Xue Za Zhi; 2022 Mar; 102(8):576-583. PubMed ID: 35196780
[No Abstract] [Full Text] [Related]
9. LncRNA HOTTIP promotes proliferation and cell cycle progression of acute myeloid leukemia cells.
Zhuang MF; Li LJ; Ma JB
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2908-2915. PubMed ID: 31002141
[TBL] [Abstract][Full Text] [Related]
10. Amplified HMGA2 promotes cell growth by regulating Akt pathway in AML.
Tan L; Wei X; Zheng L; Zeng J; Liu H; Yang S; Tan H
J Cancer Res Clin Oncol; 2016 Feb; 142(2):389-99. PubMed ID: 26319392
[TBL] [Abstract][Full Text] [Related]
11. Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant Acute Myeloid Leukemia Cells in Vitro and in Vivo.
Chen Y; Gan D; Huang Q; Luo X; Lin D; Hu J
Cell Physiol Biochem; 2018; 48(5):2061-2073. PubMed ID: 30099447
[TBL] [Abstract][Full Text] [Related]
12. LINC00987 knockdown inhibits the progression of acute myeloid leukemia by suppressing IGF2BP2-mediated PA2G4 expression.
Liu C; Ma Y; Wang R; Su G
Anticancer Drugs; 2022 Jan; 33(1):e207-e217. PubMed ID: 34407052
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype.
Liu Y; Chen Y; Liu Y; Li M; Zhang Y; Shi L; Yang L; Li T; Li Y; Jiang Z; Liu Y; Wang C; Wang S
J Transl Med; 2022 Dec; 20(1):612. PubMed ID: 36550462
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of IARS2 Inhibited Proliferation of Acute Myeloid Leukemia Cells by Regulating p53/p21/PCNA/eIF4E Pathway.
Li H; Tian Y; Li X; Wang B; Zhai D; Bai Y; Dong C; Chao X
Oncol Res; 2019 Jun; 27(6):673-680. PubMed ID: 30832756
[TBL] [Abstract][Full Text] [Related]
15. CTSB Knockdown Inhibits Proliferation and Tumorigenesis in HL-60 Cells.
Peng S; Yang Q; Li H; Pan Y; Wang J; Hu P; Zhang N
Int J Med Sci; 2021; 18(6):1484-1491. PubMed ID: 33628106
[No Abstract] [Full Text] [Related]
16. Independent oncogenic and therapeutic significance of phosphatase PRL-3 in FLT3-ITD-negative acute myeloid leukemia.
Qu S; Liu B; Guo X; Shi H; Zhou M; Li L; Yang S; Tong X; Wang H
Cancer; 2014 Jul; 120(14):2130-41. PubMed ID: 24737397
[TBL] [Abstract][Full Text] [Related]
17. Semaphorin 4D is a potential biomarker in pediatric leukemia and promotes leukemogenesis by activating PI3K/AKT and ERK signaling pathways.
Jiang H; Tang J; Qiu L; Zhang Z; Shi S; Xue L; Kui L; Huang T; Nan W; Zhou B; Zhao C; Yu M; Sun Q
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649851
[TBL] [Abstract][Full Text] [Related]
18. PPM1D Knockdown Suppresses Cell Proliferation, Promotes Cell Apoptosis, and Activates p38 MAPK/p53 Signaling Pathway in Acute Myeloid Leukemia.
Li B; Hu J; He D; Chen Q; Liu S; Zhu X; Yu M
Technol Cancer Res Treat; 2020; 19():1533033820942312. PubMed ID: 32691668
[TBL] [Abstract][Full Text] [Related]
19. p200CUX1-regulated BMP8B inhibits the progression of acute myeloid leukemia via the MAPK signaling pathway.
Wang M; Zhong L; Zhang H; Wan P; Chu X; Shao X; Chen S; Zhou Z; Yu L; Liu B
Med Oncol; 2024 May; 41(7):166. PubMed ID: 38819709
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells.
Nishioka C; Ikezoe T; Yang J; Gery S; Koeffler HP; Yokoyama A
Int J Cancer; 2009 Oct; 125(7):1710-20. PubMed ID: 19507250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
